New studies show positive results for cannabis as part of a diabetes treatment program
There have literally been thousands of research studies into the benefits of cannabis over the past decade – more than what was seen in the 50 years prior. The vast majority of the studies has shown that marijuana has the potential to combat a constantly growing number of ailments, and there doesn’t seem to be an end to the list. In one of the more recent investigations, cannabis was trialed to fight diabetes and the initial results are promising.
Diabetes affects over 30 million people in the US alone. Additionally, around 84 Americans suffer from prediabetes, a condition that sees high blood glucose levels, but not to the point of leading to a diagnosis of full-blown diabetes. In both cases, it’s possible that sufferers have to live with chronic pain that comes from damaged nerves.
While there are laboratory medicines that help to ease the pain, doctors have led a randomized, placebo-controlled, double-blind study that incorporated 16 patients who consumed cannabis. The test revealed that cannabis positively impacts diabetic neuropathy pain.
Other studies have indicated that marijuana might actually have another surprising benefit. In 2012, the BMJ (British Medical Journal) Open published the results of a study that showed that marijuana consumers had less risk of developing cannabis than those who didn’t consume.
Yet another study on “myocardial dysfunction, inflammation, oxidative/nitrative stress, cell death and interrelated signaling pathways” showed that cannabidiol (CBD) has “great therapeutic potential in the treatment of diabetic complications, and perhaps other cardiovascular disorders.”
Research into the benefits of marijuana is on the rise and the continued are advancements continue to show positive results for the natural plant. With each step forward, marijuana opponents lose another piece of their arsenal in their ill-equipped battle to suppress Mother Nature’s wonder drug.